Purisal Nebuliser Solution

About Purisal 360 mcg/3 ml Nebuliser Solution

Purisal 360 mcg/3 ml nebuliser solution is a medicine made by Incepta Pharmaceuticals Ltd. Purisal 360 mcg/3 ml nebuliser solution is used for the treatment or prevention of bronchospasm in adults, adolescents, and children who have reversible obstructive airway disease.

There are 41 brands of Levosalbutamol listed in Bangladesh. The lowest listed price is Purilin 1 mg Tablet at ৳ 0.9 per unit.

What is Purisal 360 mcg/3 ml Nebuliser Solution?

Purisal is a nebuliser solution from Incepta Pharmaceuticals Ltd., with the generic name Levosalbutamol. It works by relaxing the muscles in the airways, helping to open them and make breathing easier. The doctor decides the dose and course.

Uses of Purisal

Purisal 360 mcg/3 ml nebuliser solution is used for the treatment or prevention of bronchospasm in adults, adolescents, and children who have reversible obstructive airway disease. It is a short-acting bronchodilator. Your doctor will decide if this medicine is suitable for you and will set the dose and course.

How to use Purisal

Purisal nebuliser solution comes in unit-dose ampoules and is given by nebulisation; it needs no dilution before use. Take Purisal 360 mcg/3 ml nebuliser solution exactly as your doctor prescribes. Complete the course exactly as prescribed. Follow the instructions given by the doctor or pharmacist, and ask them if anything about using the nebuliser is unclear.

Side effects of Purisal

In a few cases, nervousness, headache, dizziness, fatigue and sleeplessness have been reported. Low blood potassium may occur, and this can be worsened by low oxygen. If you notice any side effects or they bother you, tell your doctor or pharmacist. Tell your doctor if any side effect bothers you or does not go away. Do not stop the medicine on your own.

Safety and precautions

This medicine should be used with caution in people who react strongly to sympathomimetic amines. Purisal nebuliser solution must not be injected. Before using Purisal, tell your doctor if you have heart problems, especially coronary insufficiency, high blood pressure or irregular heartbeats. Ask your doctor first if any of these apply to you.

Frequently asked questions

What does Purisal treat?

Purisal 360 mcg/3 ml nebuliser solution is used for the treatment or prevention of bronchospasm in adults, adolescents, and children who have reversible obstructive airway disease. It is a short-acting bronchodilator.

How should I take Purisal?

Purisal nebuliser solution comes in unit-dose ampoules and is given by nebulisation; it needs no dilution before use. Take Purisal 360 mcg/3 ml nebuliser solution exactly as your doctor prescribes.

Can Purisal cause side effects?

In a few cases, nervousness, headache, dizziness, fatigue and sleeplessness have been reported. Low blood potassium may occur, and this can be worsened by low oxygen.

Who should be careful with Purisal?

This medicine should be used with caution in people who react strongly to sympathomimetic amines. Purisal nebuliser solution must not be injected.

Indications

Levosalbutamol Nebuliser Solution or Inhaler  is indicated for the treatment or prevention of bronchospasm in adults, adolescents, and children with reversible obstructive airway disease.

Pharmacology

Levosalbutamol Nebuliser Solution is a sterile, clear, colorless, preservative-free solution of the hydrochloride salt of Levosalbutamol, the (R)-enantiomer of the drug substance racemic salbutamol. Levosalbutamol Hydrochloride is a relatively selective β2 adrenergic receptor agonist.

Activation of β2 adrenergic receptors on airway smooth muscle leads to the activation of adenylcyclase and to an increase in the intracellular concentration of cyclic AMP. This increase in cAMP leads to the activation of protein kinase A, which inhibits the phosphorylation of myosin and lowers intracellular ionic calcium concentrations, resulting in relaxation. Levosalbutamol relaxes the smooth muscles of all airways, from the trachea to the terminal bronchioles. Levosalbutamol acts as a functional antagonist to relax the airway irrespective of the spasmogen involved, thus protecting against all bronchoconstrictor.

Dosage & Administration

Nebuliser Solution: This Nebuliser Solutions supplied in unit-dose ampoules and requires no dilution before administration by nebulization.
  • Children (6 months-11 years): The recommended dosage is 0.31 mg administered three times a day, by nebulization. Routine dosing should not exceed 0.63 mg three times a day. 
  • Adults and Adolescents above 12 years old: The recommended starting dosage is 0.63 mg administered three to four times a day, every 6 to 8 hours, by nebulization. 
  • Patients 12 years of age and older: With more severe asthma or patients who do not respond adequately: 0.63 mg of Levosalbutamol Nebuliser Solution may benefit from a dosage of 1.25 mg three times a day.
Inhaler: You should take your Levosalbutamol Inhaler as needed for an asthma attack at any time of day, with or without food, by taking 1-2 puffs up to 4 times daily and no more than 8 puffs in 24 hours. If you are using your Levosalbutamol Inhaler more than 3-4 times a week this may indicate that your asthma is not well controlled and you may need to review your medication. You can also use your Levosalbutamol Inhaler to prevent allergy or exercise induced asthma by taking 2 puffs 15 minutes before exercise or exposure to a known allergen.

Interaction

Other short-acting sympathomimetic aerosol bronchodilators or epinephrine should be used with caution with Levosalbutamol. If additional adrenergic drugs are to be administered by any route, they should be used with caution to avoid deleterious cardiovascular effects.

Beta-blockers: Beta-adrenergic receptor blocking agents not only block the pulmonary effect of beta-agonists such as Levosalbutamol Nebuliser Solution or Inhaler, but may also produce severe bronchospasm in asthmatic patients. However, under certain circumstances, e.g. prophylaxis after myocardial infarction, there may be no acceptable alternatives to the use of beta-adrenergic blocking agents in patients with asthma. In this setting, cardio selective beta-blockers could be considered with caution.

Diuretics: The ECG changes and/or hypokalemia that may result from the administration of non-potassium sparing diuretics can be acutely worsened by beta-agonists when the recommended dose of the beta-agonist is exceeded.

Digoxin: It is necessary to carefully evaluate the serum digoxin levels in patients who are currently receiving digoxin and Levosalbutamol Nebuliser Solution or Inhaler. 

Monoamine Oxidase Inhibitors or Tricyclic Antidepressants: Levosalbutamol Nebuliser Solution or Inhaler should be administered with extreme caution to patients being treated with monoamine oxidase inhibitors or tricyclic antidepressants, or within 2 weeks of discontinuation of such agents.

Side Effects

Potentially serious hypokalaemia may result from beta 2 - agonist therapy. This effect may be potentiated by hypoxia. Other side effects such as palpitation, fine tremors of the skeletal muscle (particularly the hand) and muscle cramps may occur. In few cases nervousness, headache, dizziness, fatigue and sleeplessness have also been reported.

Pregnancy & Lactation

Pregnancy: There are no adequate and well-controlled studies of Levosalbutamol Nebuliser Solution in pregnant women. Levosalbutamol Solution should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus.

Lactation: It is not known whether Levosalbutamol is excreted in human milk. Caution should be exercised when Levosalbutamol Nebuliser Solution is administered to a nursing woman.

Precautions & Warnings

Levosalbutamol Hydrochloride, like all sympathomimetic amines, should be used with caution in patients with cardiovascular disorders, especially coronary insufficiency, hypertension, and cardiac arrhythmias; in patients with convulsive disorders, hyperthyroidism, or diabetes mellitus; and in patients who are unusually responsive to sympathomimetic amines. Levosalbutamol Nebuliser Solution or Inhaler must not be injected.

Overdose Effects

The expected symptoms with over dosage are those of excessive beta-adrenergic receptor stimulation and/or occurrence or exaggeration of any of the symptoms listed under side effects. Treatment consists of discontinuation of Levosalbutamol Nebuliser Solution or Inhaler together with appropriate symptomatic therapy. The judicious use of a cardioselective beta-receptor blocker may be considered.

Storage Conditions

Store below 25°C. Protect from light. Do not refrigerate.

Alternative brands of Levosalbutamol

Other brands with the same generic name, cheapest first.

See all 41 brands

Medicine information is for reference only and is not medical advice. Always follow your doctor's prescription and check with a pharmacist.